Marksans Pharma Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 339.98 | 262.68 | 237.39 |
| Operating Expense | 256.35 | 213.26 | 191.29 |
| Net Profit | 63.20 | 32.02 | 32.99 |
| Net Profit Margin | 18.59 | 12.19 | 13.90 |
| Earning Per Share | 1.39 | 0.71 | 0.73 |
| EBIDTA | 83.11 | 49.50 | 49.20 |
| Effective Tax Rate | 15.08 | 20.96 | 18.46 |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 339.98 |
| Operating Expense | 256.35 |
| Net Profit | 63.20 |
| Net Profit Margin | 18.59 |
| Earning Per Share | 1.39 |
| EBIDTA | 83.11 |
| Effective Tax Rate | 15.08 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| Total Revenue Annual | 655.20 | 658.29 | 599.55 |
| Operating Expenses Annual | 563.30 | 544.57 | 485.84 |
| Operating Profit Annual | 152.39 | 155.97 | 144.87 |
| Interest Annual | 3.61 | 3.80 | 5.35 |
| Depreciation | 16.15 | 17.07 | 14.60 |
| Net Profit Annual | 102.87 | 103.99 | 98.38 |
| Tax Annual | 29.17 | 30.52 | 25.95 |
| Particulars | Mar 2023 |
|---|---|
| Total Revenue Annual | 655.20 |
| Operating Expenses Annual | 563.30 |
| Operating Profit Annual | 152.39 |
| Interest Annual | 3.61 |
| Depreciation | 16.15 |
| Net Profit Annual | 102.87 |
| Tax Annual | 29.17 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 148.31 | 81.19 | 82.42 |
| Cash Flow from Operations | 34.05 | 51.73 | 55.97 |
| Cash Flow from Investing | -114.22 | -194.62 | -128.06 |
| Cash Flow from Financing | -26.22 | 210.02 | 70.86 |
| Cash Flow at the End | 41.93 | 148.31 | 81.19 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 148.31 |
| Cash Flow from Operations | 34.05 |
| Cash Flow from Investing | -114.22 |
| Cash Flow from Financing | -26.22 |
| Cash Flow at the End | 41.93 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 23.67 | 23.26 | 23.69 |
| PBIT Margin (%) | 20.26 | 20.70 | 21.01 |
| PBT Margin (%) | -0.21 | 14.96 | 15.48 |
| Net PROFIT Margin (%) | 15.68 | 15.70 | 15.80 |
| Return On Networth / Equity (%) | 11.46 | 10.85 | 15.02 |
| Return On Networth /Employed (%) | 14.67 | 14.11 | 19.45 |
| Return On Assets (%) | 11.29 | 10.68 | 14.69 |
| Total Debt / Equity (X) | 0.01 | 0.01 | 0.02 |
| Asset Turnover Ratio (%) | 0.72 | 0.68 | 0.93 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 23.67 |
| PBIT Margin (%) | 20.26 |
| PBT Margin (%) | -0.21 |
| Net PROFIT Margin (%) | 15.68 |
| Return On Networth / Equity (%) | 11.46 |
| Return On Networth /Employed (%) | 14.67 |
| Return On Assets (%) | 11.29 |
| Total Debt / Equity (X) | 0.01 |
| Asset Turnover Ratio (%) | 0.72 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 271.58 | 143.94 | 135.51 |
| Total Current Assets Annual | 947.70 | 913.76 | 589.86 |
| Non Current Assets Annual | 568.33 | 431.10 | 375.75 |
| Total Shareholders Funds Annual | 1,222.71 | 1,111.32 | 784.67 |
| Total Assets Annual | 1,516.04 | 1,344.86 | 965.61 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 271.58 |
| Total Current Assets Annual | 947.70 |
| Non Current Assets Annual | 568.33 |
| Total Shareholders Funds Annual | 1,222.71 |
| Total Assets Annual | 1,516.04 |
EPS (INR)
Expected
2.13
Reported
2.13
Surprise
0.00%
Jun 2024
EPS beaten by 0.00%
Mar 2024
EPS beaten by 0.00%
Dec 2023
EPS beaten by 0.00%
